Screener

Eligibility screening

Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Sponsored by Nationwide Children's HospitalStudy detailsClinicalTrials.gov

11 US sites in CO, DC, IL, MA +6

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.